Dr. Paul Mike Jordan
Institut für Pharmazeutische Chemie
Friedrich-Schiller-Universität Jena
Philosophenweg 14
07743 Jena
Telefon: + 49 3641 948 827
Telefax: + 49 3641 948 827
paul.jordan@uni-jena.de
Homepage
Funktionen
- Wissenschaftlicher Mitarbeiter
Forschungsgebiete
- Rolle von Lipidmediatoren bei Entzündungen
- Entwicklung von dualen/multiplen Enzyminhibitoren
- Molekulare und zelluläre Mechanismen von Naturstoffen
Publikationen (die 5 wichtigsten)
- Jordan PM. et al. Staphylococcus aureus-Derived α-Hemolysin Evokes Generation of Specialized Pro-resolving Mediators Promoting Inflammation Resolution. Cell Rep. 2020 Oct 13;33(2):108247.
- Jordan PM, Werz O. Specialized pro-resolving mediators: biosynthesis and biological role in bacterial infections. FEBS J. 2022 Jul;289(14):4212-4227.
- Jordan PM et al. ATP/IL-33-triggered hyperactivation of mast cells results in an amplified production of pro-inflammatory cytokines and eicosanoids. Immunology. 2021 Nov;164(3):541-554.
- Jordan PM et al. The Natural Combination Medicine Traumeel (Tr14) Improves Resolution of Inflammation by Promoting the Biosynthesis of Specialized Pro-Resolving Mediators. Pharmaceuticals (Basel). 2021 Nov 3;14(11):1123.
- Werner M, Jordan PM et al. Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome. FASEB J. 2019 May;33(5):6140-6153.